Vera Therapeutics, Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VERA, updated each market day.
VERA AI Sentiment
AI predicts Vera Therapeutics, Inc. Class A Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Vera Therapeutics, Inc. Class A Common Stock
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Sector
Exchange
Market Cap
$2,920,587,450
Cap Tier
Employees
249
Headquarters
BRISBANE, CA
Listed Since
May 14, 2021
Website
VERA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VERA Volatility
Vera Therapeutics, Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
